Home/Filings/4/0001415889-25-018305
4//SEC Filing

Leheny A. Rachel 4

Accession 0001415889-25-018305

CIK 0001534133other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 6:26 PM ET

Size

6.1 KB

Accession

0001415889-25-018305

Insider Transaction Report

Form 4
Period: 2025-06-24
Leheny A. Rachel
DirectorCHIEF EXECUTIVE OFFICER10% Owner
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2025-06-24+77,62577,625 total
    Exercise: $1.53Exp: 2035-04-22Common Stock (77,625 underlying)
Footnotes (2)
  • [F1]The option grant was approved by the Board of Directors of CalciMedica, Inc. (the "Company") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the "Amended 2023 EIP") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025.
  • [F2]Immediately exercisable.

Issuer

CalciMedica, Inc.

CIK 0001534133

Entity typeother

Related Parties

1
  • filerCIK 0001484729

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 6:26 PM ET
Size
6.1 KB